Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index; 17 of the 25 sources its claims cite were checked for support.

Decision Support and Behavioral Health for Reducing High-Dose Opioids in Comorbid Chronic Pain, Depression and Anxiety: Stepped-Wedge Cluster Randomized Trial

Open access
Price-Haywood, Eboni G., Burton, Jeffrey H., Harden-Barrios, Jewel, Bazzano, Alessandra, Shi, Lizheng, Lefante, John, Jamison, Robert N · 2024 · Journal of General Internal Medicine

Abstract

Background: High prevalence of depression or anxiety with opioid use for chronic pain complicates co-management and may influence prescribing behaviors. Objective: Compare clinical effectiveness of electronic medical record clinical decision support (EMR-CDS) versus additional behavioral health (BH) care management for reducing rates of high-dose opioid prescriptions. Design: Type 2 effectiveness-implementation hybrid stepped-wedge cluster randomized trial in 35 primary care clinics within a health system in LA, USA. Participants: Patients aged 18+ receiving chronic opioid therapy for non-cancer pain with depression or anxiety and matched controls. Intervention: EMR-CDS included opioid risk mitigation procedures. BH care included cognitive behavioral therapy; depression or anxiety medication adjustments; and case management. Main Measures: Outcomes of interest included difference-in-difference (DID) estimate of changes in probability for prescribing high-dose morphine equivalent daily dose (MEDD ≥50 mg/day and MEDD ≥90), average MEDD, and rates of hospitalization, emergency department use, and opioid risk mitigation. Key Results: Most participants were female with 3+ pain syndromes. Data analysis included 632 patients. Absolute risk differences for MEDD≥50 and ≥90 decreased post-index compared to pre-index (DID of absolute risk difference [95%CI]: −0.036 [−0.089, 0.016] and −0.029 [−0.060, 0.002], respectively). However, these differences were not statistically significant. The average MEDD decreased at a higher rate for the BH group compared to EMR-CDS only (DID rate ratio [95%CI]: 0.85 [0.77, 0.93]). There were no changes in hospitalization and emergency department utilization. The BH group had higher probabilities of new specialty referrals and prescriptions for naloxone and antidepressants. Conclusions: Incorporation of a multidisciplinary behavioral health care team into primary care did not decrease high-dose prescribing; however, it improved adherence to clinical guideline recommendations for managing chronic opioid therapy for non-cancer pain. Trial Registration: ClinicalTrials.gov ID NCT03889418 © The Author(s), under exclusive licence to Society of General Internal Medicine 2024.

Overview

CoChat Summary

TL;DR

In this stepped-wedge cluster randomized trial across 35 primary care clinics, adding multidisciplinary behavioral health care to EMR clinical decision support did not significantly reduce high-dose opioid prescribing, but it did improve opioid risk-mitigation and some patient symptoms. The average morphine equivalent daily dose (MEDD) fell more in the behavioral health group than in usual care (DID rate ratio 0.85, 95% CI 0.77–0.93).

Key findings

  • The study included 632 adults in the final analysis; baseline average MEDD was 47.1 mg/day, 26.9% had MEDD ≥50 mg/day, and 10.3% had MEDD ≥90 mg/day.
  • High-dose opioid prescribing did not significantly differ by group: DID for MEDD ≥50 was -0.036 (95% CI -0.089, 0.016) and for MEDD ≥90 was -0.029 (95% CI -0.060, 0.002).
  • Average MEDD decreased more in the behavioral health group than in EMR-CDS usual care: DID rate ratio 0.85 (95% CI 0.77, 0.93).
  • Behavioral health care had higher probabilities of new specialty referrals and naloxone and antidepressant prescriptions; the paper also reports symptom improvements in the behavioral health group, including PHQ-9 <10 in 62% of those with baseline PHQ-9 ≥10, GAD-7 <10 in 57% with baseline GAD-7 ≥10, PEG-3 down by 1.3 points, and COMM-9 down by 1.1.

Methods

  • Type 2 effectiveness-implementation hybrid stepped-wedge cluster randomized trial in 35 primary care clinics within Ochsner Health in Louisiana; five geographic regions were randomized to rollout order in five steps at 3- to 4-month intervals from April 2019 to May 2020.
  • Eligible patients were adults 18+ on chronic opioid therapy for non-cancer pain with documented depression or anxiety; 656 were eligible and 632 were included in analysis. Matched controls came from the same health system and were propensity score matched, up to two controls per behavioral health patient.
  • Main analyses used generalized linear mixed models with random intercepts for patient and study region and a difference-in-differences framework, with binary MEDD outcomes analyzed via absolute risk differences and continuous service-use/dose outcomes modeled with Poisson or negative binomial distributions as appropriate.

Limitations

  • The paper states it was conducted at one institution, limiting external generalizability.
  • The authors state causal inferences cannot be drawn because randomization of patients was not practical and matched controls were used instead; they also note possible selection bias among referred/enrolled patients.
  • Fourteen behavioral health patients had inaccessible opioid prescription data from outside providers and were excluded from the MEDD analysis; the paper states it cannot determine the direction of bias from this missing data.
  • Evident from the text: patient-reported outcomes were not consistently documented as structured data in the usual care arm, so between-group comparison of those outcomes was not possible.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1007/s11606-024-08965-7

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

14 Valid · 1 Not valid · 5 Not checked · 63 Own results and interpretations

34 more claims · 2 with their cited sources checked

Create a free account to see all 83 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 29
  • It may state two separate claims as one. 19
  • Borderline: one of the tests for a substantial claim is unclear. 1
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 36 references

Cited by

See all 2

Metadata

Authors
Price-Haywood, E. G., Burton, J. H., Harden-Barrios, J., Bazzano, A., Shi, L., Lefante, J., & Jamison, R. N.
Affiliations
  • Ochsner Health System (US)
  • Tulane University (US)
  • Brigham and Women's Hospital (US)
Venue
Journal of General Internal Medicine
Published
2024-08-02
Volume
39
Issue
15
Pages
2952-2960
ISSN
  • 0884-8734 (ISSN-L)
  • 1525-1497
OpenAlex
W4401243528
Cited by
2
References
36
Citations by year
2026: 2
FWCI
0.82
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of General Internal Medicine (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion)
Funders
National Institute on Drug Abuse (1R01DA045029)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
  • Health Sciences › Health Professions › Health Information Management › Electronic Health Records Systems
Keywords
chronic pain, depression, anxiety, clinical decision support, electronic health records, cognitive behavioral therapy, non-cancer pain, primary care, naloxone, antidepressants, hospitalization, emergency department utilization, guideline adherence
MeSH terms
Adult, Aged, Analgesics, Opioid, Anxiety, Depression, Female, Humans, Male, Middle Aged, Comorbidity, Cluster Analysis, Decision Support Systems, Clinical, Electronic Health Records, Chronic Pain

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Decision Support and Behavioral Health for Reducing High-Dose Opioids in Comorbid Chronic Pain, Depression and Anxiety: Stepped-Wedge Cluster Randomized Trial. https://app.cochat.ai/papers/10.1007/s11606-024-08965-7
The paper
Price-Haywood, E. G., Burton, J. H., Harden-Barrios, J., Bazzano, A., Shi, L., Lefante, J., & Jamison, R. N. (2024). Decision Support and Behavioral Health for Reducing High-Dose Opioids in Comorbid Chronic Pain, Depression and Anxiety: Stepped-Wedge Cluster Randomized Trial. Journal of General Internal Medicine. https://doi.org/10.1007/s11606-024-08965-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.